Melatonin Suppresses Renal Cortical Fibrosis by Inhibiting Cytoskeleton Reorganization and Mitochondrial Dysfunction through Regulation of miR-4516
暂无分享,去创建一个
J. H. Lee | C. Yun | Sang Hun Lee | Y. Yoon | Gyeongyun Go | J. Lim
[1] L. G. Vu,et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The Lancet.
[2] J. H. Lee,et al. Melatonin‐stimulated exosomes enhance the regenerative potential of chronic kidney disease‐derived mesenchymal stem/stromal cells via cellular prion proteins , 2020, Journal of pineal research.
[3] J. H. Lee,et al. Melatonin Enhances Mitophagy by Upregulating Expression of Heat Shock 70 kDa Protein 1L in Human Mesenchymal Stem Cells under Oxidative Stress , 2019, International journal of molecular sciences.
[4] Valérie Metzinger-Le Meuth,et al. miR-223 and other miRNA's evaluation in chronic kidney disease: Innovative biomarkers and therapeutic tools , 2019, Non-coding RNA research.
[5] R. Beroukhim,et al. miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma , 2018, Oncogene.
[6] Cheng Yang,et al. Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury , 2018, Cell Death & Disease.
[7] J. H. Lee,et al. Pioglitazone Protects Mesenchymal Stem Cells against P-Cresol-Induced Mitochondrial Dysfunction via Up-Regulation of PINK-1 , 2018, International journal of molecular sciences.
[8] J. H. Lee,et al. Melatonin Promotes Apoptosis of Oxaliplatin-resistant Colorectal Cancer Cells Through Inhibition of Cellular Prion Protein. , 2018, Anticancer research.
[9] S. Yun,et al. Melatonin Rescues Mesenchymal Stem Cells from Senescence Induced by the Uremic Toxin p-Cresol via Inhibiting mTOR-Dependent Autophagy , 2017, Biomolecules & therapeutics.
[10] N. Saini,et al. miR-4516, a microRNA downregulated in psoriasis inhibits keratinocyte motility by targeting fibronectin/integrin α9 signaling. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[11] J. Vallée,et al. Diagnosis and assessment of renal fibrosis: the state of the art. , 2017, Swiss medical weekly.
[12] J. H. Lee,et al. Potentiation of biological effects of mesenchymal stem cells in ischemic conditions by melatonin via upregulation of cellular prion protein expression , 2017, Journal of pineal research.
[13] R. Chen,et al. Role of microRNA-4516 involved autophagy associated with exposure to fine particulate matter , 2016, Oncotarget.
[14] Mitsuo Kato,et al. Mini-review: emerging roles of microRNAs in the pathophysiology of renal diseases. , 2016, American journal of physiology. Renal physiology.
[15] P. Olinga,et al. Chronic Kidney Disease and Fibrosis: The Role of Uremic Retention Solutes , 2015, Front. Med..
[16] M. Breuning,et al. Scattered Deletion of PKD1 in Kidneys Causes a Cystic Snowball Effect and Recapitulates Polycystic Kidney Disease. , 2015, Journal of the American Society of Nephrology : JASN.
[17] R. Neubig,et al. Cellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription. , 2014, American journal of physiology. Cell physiology.
[18] Songming Huang,et al. Mitochondrial dysfunction in the pathophysiology of renal diseases. , 2014, American journal of physiology. Renal physiology.
[19] Q. Mi,et al. The regulation and function of micrornas in kidney diseases , 2013, IUBMB life.
[20] S. Kauppinen,et al. Treatment of HCV infection by targeting microRNA. , 2013, The New England journal of medicine.
[21] J. Chun,et al. LPA1‐induced cytoskeleton reorganization drives fibrosis through CTGF‐dependent fibroblast proliferation , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] T. Hewitson. Fibrosis in the kidney: is a problem shared a problem halved? , 2012, Fibrogenesis & tissue repair.
[23] R. Reiter,et al. Melatonin membrane receptors in peripheral tissues: Distribution and functions , 2012, Molecular and Cellular Endocrinology.
[24] Aaron N. Chang,et al. MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways , 2012, Science Translational Medicine.
[25] Luca Scorrano,et al. The relationship between mitochondrial shape and function and the cytoskeleton. , 2006, Biochimica et biophysica acta.
[26] M. Couillard,et al. Overexpression of PKD1 Causes Polycystic Kidney Disease , 2006, Molecular and Cellular Biology.
[27] Jiahuai Han,et al. β-actin is required for mitochondria clustering and ROS generation in TNF-induced, caspase-independent cell death , 2004, Journal of Cell Science.
[28] Lindsay N. Carpp,et al. A role for the actin cytoskeleton in cell death and aging in yeast , 2004, The Journal of cell biology.
[29] Gregory R Pond,et al. The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. , 2002, Journal of the American Society of Nephrology : JASN.
[30] P. Barrett,et al. Melatonin receptors in the human fetal kidney: 2-[125I]iodomelatonin binding sites correlated with expression of Mel1a and Mel1b receptor genes. , 1998, The Journal of endocrinology.
[31] G. Brown,et al. Studies of the renal action of melatonin: evidence that the effects are mediated by 37 kDa receptors of the Melia subtype localized primarily to the basolateral membrane of the proximal tubule , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.